experimental therapy

H9-T cell infected by HIV
Biotech

Shionogi licenses out 3rd-gen HIV asset to ViiV

Japanese pharma Shionogi has penned a new licensing deal for a long-acting HIV asset from ViiV.
Ben Adams Sep 28, 2021 9:10am
gene therapy manufacturing facility

Another death blights Astellas' $3B Audentes buy

Sep 14, 2021 3:45am
Dry eye

Adverum shares halved after trial patient goes blind in one eye

Apr 29, 2021 7:30am
Hospital COVID Healthcare workers during an intubation procedure to a COVID patient

How GeNeuro's experimental MS drug might help treat COVID-19

Apr 15, 2021 1:30am
Tivoli Gardens Copenhagen Denmark

Orphazyme shares sink as late-stage test flops

Mar 29, 2021 8:50am
Chrysler Building New York

Immunovant hits the pause button for eye drug

Feb 2, 2021 9:25am